pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-570 |
Genomic Coordinates | chr3: 195699401 - 195699497 |
Synonyms | MIRN570, hsa-mir-570, MIR570 |
Description | Homo sapiens miR-570 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-570-3p | |||||||||||||||||||||||||||||||||
Sequence | 60| CGAAAACAGCAAUUACCUUUGC |81 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | SAGE | |||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CD274 | ||||||||||||||||||||
Synonyms | B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1 | ||||||||||||||||||||
Description | CD274 molecule | ||||||||||||||||||||
Transcript | NM_014143 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CD274 | |||||||||||||||||||||
3'UTR of CD274 (miRNA target sites are highlighted) |
>CD274|NM_014143|3'UTR 1 TCCAGCATTGGAACTTCTGATCTTCAAGCAGGGATTCTCAACCTGTGGTTTAGGGGTTCATCGGGGCTGAGCGTGACAAG 81 AGGAAGGAATGGGCCCGTGGGATGCAGGCAATGTGGGACTTAAAAGGCCCAAGCACTGAAAATGGAACCTGGCGAAAGCA 161 GAGGAGGAGAATGAAGAAAGATGGAGTCAAACAGGGAGCCTGGAGGGAGACCTTGATACTTTCAAATGCCTGAGGGGCTC 241 ATCGACGCCTGTGACAGGGAGAAAGGATACTTCTGAACAAGGAGCCTCCAAGCAAATCATCCATTGCTCATCCTAGGAAG 321 ACGGGTTGAGAATCCCTAATTTGAGGGTCAGTTCCTGCAGAAGTGCCCTTTGCCTCCACTCAATGCCTCAATTTGTTTTC 401 TGCATGACTGAGAGTCTCAGTGTTGGAACGGGACAGTATTTATGTATGAGTTTTTCCTATTTATTTTGAGTCTGTGAGGT 481 CTTCTTGTCATGTGAGTGTGGTTGTGAATGATTTCTTTTGAAGATATATTGTAGTAGATGTTACAATTTTGTCGCCAAAC 561 TAAACTTGCTGCTTAATGATTTGCTCACATCTAGTAAAACATGGAGTATTTGTAAGGTGCTTGGTCTCCTCTATAACTAC 641 AAGTATACATTGGAAGCATAAAGATCAAACCGTTGGTTGCATAGGATGTCACCTTTATTTAACCCATTAATACTCTGGTT 721 GACCTAATCTTATTCTCAGACCTCAAGTGTCTGTGCAGTATCTGTTCCATTTAAATATCAGCTTTACAATTATGTGGTAG 801 CCTACACACATAATCTCATTTCATCGCTGTAACCACCCTGTTGTGATAACCACTATTATTTTACCCATCGTACAGCTGAG 881 GAAGCAAACAGATTAAGTAACTTGCCCAAACCAGTAAATAGCAGACCTCAGACTGCCACCCACTGTCCTTTTATAATACA 961 ATTTACAGCTATATTTTACTTTAAGCAATTCTTTTATTCAAAAACCATTTATTAAGTGCCCTTGCAATATCAATCGCTGT 1041 GCCAGGCATTGAATCTACAGATGTGAGCAAGACAAAGTACCTGTCCTCAAGGAGCTCATAGTATAATGAGGAGATTAACA 1121 AGAAAATGTATTATTACAATTTAGTCCAGTGTCATAGCATAAGGATGATGCGAGGGGAAAACCCGAGCAGTGTTGCCAAG 1201 AGGAGGAAATAGGCCAATGTGGTCTGGGACGGTTGGATATACTTAAACATCTTAATAATCAGAGTAATTTTCATTTACAA 1281 AGAGAGGTCGGTACTTAAAATAACCCTGAAAAATAACACTGGAATTCCTTTTCTAGCATTATATTTATTCCTGATTTGCC 1361 TTTGCCATATAATCTAATGCTTGTTTATATAGTGTCTGGTATTGTTTAACAGTTCTGTCTTTTCTATTTAAATGCCACTA 1441 AATTTTAAATTCATACCTTTCCATGATTCAAAATTCAAAAGATCCCATGGGAGATGGTTGGAAAATCTCCACTTCATCCT 1521 CCAAGCCATTCAAGTTTCCTTTCCAGAAGCAACTGCTACTGCCTTTCATTCATATGTTCTTCTAAAGATAGTCTACATTT 1601 GGAAATGTATGTTAAAAGCACGTATTTTTAAAATTTTTTTCCTAAATAGTAACACATTGTATGTCTGCTGTGTACTTTGC 1681 TATTTTTATTTATTTTAGTGTTTCTTATATAGCAGATGGAATGAATTTGAAGTTCCCAGGGCTGAGGATCCATGCCTTCT 1761 TTGTTTCTAAGTTATCTTTCCCATAGCTTTTCATTATCTTTCATATGATCCAGTATATGTTAAATATGTCCTACATATAC 1841 ATTTAGACAACCACCATTTGTTAAGTATTTGCTCTAGGACAGAGTTTGGATTTGTTTATGTTTGCTCAAAAGGAGACCCA 1921 TGGGCTCTCCAGGGTGCACTGAGTCAATCTAGTCCTAAAAAGCAATCTTATTATTAACTCTGTATGACAGAATCATGTCT 2001 GGAACTTTTGTTTTCTGCTTTCTGTCAAGTATAAACTTCACTTTGATGCTGTACTTGCAAAATCACATTTTCTTTCTGGA 2081 AATTCCGGCAGTGTACCTTGACTGCTAGCTACCCTGTGCCAGAAAAGCCTCATTCGTTGTGCTTGAACCCTTGAATGCCA 2161 CCAGCTGTCATCACTACACAGCCCTCCTAAGAGGCTTCCTGGAGGTTTCGAGATTCAGATGCCCTGGGAGATCCCAGAGT 2241 TTCCTTTCCCTCTTGGCCATATTCTGGTGTCAATGACAAGGAGTACCTTGGCTTTGCCACATGTCAAGGCTGAAGAAACA 2321 GTGTCTCCAACAGAGCTCCTTGTGTTATCTGTTTGTACATGTGCATTTGTACAGTAATTGGTGTGACAGTGTTCTTTGTG 2401 TGAATTACAGGCAAGAATTGTGGCTGAGCAAGGCACATAGTCTACTCAGTCTATTCCTAAGTCCTAACTCCTCCTTGTGG 2481 TGTTGGATTTGTAAGGCACTTTATCCCTTTTGTCTCATGTTTCATCGTAAATGGCATAGGCAGAGATGATACCTAATTCT 2561 GCATTTGATTGTCACTTTTTGTACCTGCATTAATTTAATAAAATATTCTTATTTATTTTGTTACTTGGTACACCAGCATG 2641 TCCATTTTCTTGTTTATTTTGTGTTTAATAAAATGTTCAGTTTAACATCCCAGTGGAGAAAGTTAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | SGC7901 |
Disease | gastric adenocarcinoma |
Location of target site | 3'UTR |
Tools used in this research | miRanda , TargetScan |
Original Description (Extracted from the article) |
...
a novel regulatory mechanism for CD274 overexpression in gastric cancer mediated by miR-570 and somatic mutation in CD274 3'UTR and provide a new insight to gastric carcinogenesis
... - Wang W; Sun J; Li F; Li R; Gu Y; Liu C; et al., 2012, Human mutation. |
Article |
- Wang W; Sun J; Li F; Li R; Gu Y; Liu C; et al. - Human mutation, 2012
Inhibitory costimulatory molecule CD274 expresses in various cancers and contributes to cancer immune evasion by inhibiting T cell activation and proliferation, yet the regulatory mechanisms for CD274 overexpression in cancers are poorly understood. In this study, we discovered a novel mechanism of CD274 expression regulated by miR-570. A guanine-to-cytosine mutation at the 3'-UTR of CD274 mRNA led to CD274 overexpression by disrupting the miR-570 binding. The mutations were widely observed in cancers by sequencing of 276 gastrointestinal cancers (esophageal, gastric, colorectal, hepatocellular, and pancreatic cancers). This mutation was significantly associated with CD274 overexpression in gastric cancer (P = 1.44x10(-10)) and with the pathological features including differentiation grade, depth of tumor invasion, lymph node metastasis, and tumor-node-metastases (TNM) stage. These findings suggest a novel regulatory mechanism for CD274 overexpression in gastric cancer mediated by miR-570 and a somatic mutation in CD274 3'-UTR, and provide a new insight to gastric carcinogenesis.
LinkOut: [PMID: 22190470]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | SGC7901 |
Disease | gastric cancer |
Location of target site | 3'UTR |
Tools used in this research | miRanda , TargetScan |
Original Description (Extracted from the article) |
...
SNP might be responsible for aberrrant B7-H1 protein expression in gastric cancer by distrrupting the interaction between miR-570 and B7-H1 mRNA
... - Wang W; Li F; Mao Y; Zhou H; Sun J; Li R; et al., 2013, Human genetics. |
Article |
- Wang W; Li F; Mao Y; Zhou H; Sun J; Li R; et al. - Human genetics, 2013
Single nucleotide polymorphisms (SNPs) in putative microRNA (miRNA) target sites (miRSNPs) could affect the binding of miRNA with the target and contribute to the susceptibility of human cancers. However, the role of miRSNPs in gastric cancer susceptibility remains largely unknown. Since the over-expression of B7-H1 protein has been reported to be closely related to disease progression of gastric cancer, we investigated the possible role of miRSNPs at the 3'-untranslated region (3'-UTR) of B7-H1 in the risk of developing gastric cancer. In this association study on 205 gastric adenocarcinoma patients and 393 non-cancer controls, we found that the genotype distribution of a common C>G polymorphism (rs4143815) was significantly different between the cases and controls (P = 1.32 x 10(-8)). Compared with CC homozygotes, GG homozygotes and G allele carriers showed 3.73-fold (P = 2.98 x 10(-8)) and 1.85-fold (P = 0.002) increased risk of gastric adenocarcinoma, respectively. Stratified analyses indicated that variant genotypes had a strong association with the clinic-pathological features of gastric cancer including differentiation grade, depth of tumor infiltration, and tumor node metastasis (TNM) stage (P < 0.001). Luciferase reporter assay indicated that this SNP might be responsible for aberrant B7-H1 protein expression in gastric cancer by disrupting the interaction between miR-570 and B7-H1 mRNA. These results are consistent with our hypothesis and indicate that genetic polymorphisms influencing B7-H1 expression modify cancer susceptibility.
LinkOut: [PMID: 23430453]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
166 hsa-miR-570-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT053484 | CD274 | CD274 molecule | 2 | 2 | ||||||||
MIRT056153 | OTUD1 | OTU deubiquitinase 1 | 2 | 2 | ||||||||
MIRT057406 | TNKS2 | tankyrase 2 | 2 | 2 | ||||||||
MIRT065096 | SLC38A1 | solute carrier family 38 member 1 | 2 | 2 | ||||||||
MIRT073901 | ARL6IP1 | ADP ribosylation factor like GTPase 6 interacting protein 1 | 2 | 8 | ||||||||
MIRT074322 | TNRC6A | trinucleotide repeat containing 6A | 2 | 8 | ||||||||
MIRT077514 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 4 | ||||||||
MIRT082532 | CALM3 | calmodulin 3 | 2 | 2 | ||||||||
MIRT084575 | BCL2L11 | BCL2 like 11 | 2 | 4 | ||||||||
MIRT092028 | ABHD5 | abhydrolase domain containing 5 | 2 | 6 | ||||||||
MIRT099121 | MYLIP | myosin regulatory light chain interacting protein | 2 | 8 | ||||||||
MIRT102992 | RBM33 | RNA binding motif protein 33 | 2 | 8 | ||||||||
MIRT105434 | ATP6V1B2 | ATPase H+ transporting V1 subunit B2 | 2 | 10 | ||||||||
MIRT109568 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT145281 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT150161 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT167432 | TRIP13 | thyroid hormone receptor interactor 13 | 2 | 2 | ||||||||
MIRT168486 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 2 | 4 | ||||||||
MIRT172128 | KLF10 | Kruppel like factor 10 | 4 | 2 | ||||||||
MIRT215596 | SUB1 | SUB1 homolog, transcriptional regulator | 2 | 2 | ||||||||
MIRT259928 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 2 | ||||||||
MIRT274852 | ATXN7L3B | ataxin 7 like 3B | 2 | 4 | ||||||||
MIRT290491 | C18ORF25 | chromosome 18 open reading frame 25 | 2 | 2 | ||||||||
MIRT290941 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 4 | ||||||||
MIRT322703 | BAG4 | BCL2 associated athanogene 4 | 2 | 2 | ||||||||
MIRT358568 | CANX | calnexin | 2 | 2 | ||||||||
MIRT381250 | RMND5A | required for meiotic nuclear division 5 homolog A | 2 | 2 | ||||||||
MIRT442077 | NDRG1 | N-myc downstream regulated 1 | 2 | 2 | ||||||||
MIRT442943 | C17orf105 | chromosome 17 open reading frame 105 | 2 | 2 | ||||||||
MIRT444267 | ATOX1 | antioxidant 1 copper chaperone | 2 | 2 | ||||||||
MIRT444365 | TIMM8B | translocase of inner mitochondrial membrane 8 homolog B | 2 | 2 | ||||||||
MIRT444863 | SAMD12 | sterile alpha motif domain containing 12 | 2 | 2 | ||||||||
MIRT444871 | ISPD | isoprenoid synthase domain containing | 2 | 2 | ||||||||
MIRT445077 | CXXC4 | CXXC finger protein 4 | 2 | 2 | ||||||||
MIRT445717 | NAP1L6 | nucleosome assembly protein 1 like 6 | 2 | 2 | ||||||||
MIRT445945 | SCML4 | Scm polycomb group protein like 4 | 2 | 2 | ||||||||
MIRT446054 | NR5A2 | nuclear receptor subfamily 5 group A member 2 | 2 | 2 | ||||||||
MIRT446704 | FUT10 | fucosyltransferase 10 | 2 | 2 | ||||||||
MIRT446726 | SPAG11A | sperm associated antigen 11A | 2 | 2 | ||||||||
MIRT447147 | HHIP | hedgehog interacting protein | 2 | 2 | ||||||||
MIRT447566 | LLPH | LLP homolog, long-term synaptic facilitation | 2 | 2 | ||||||||
MIRT448698 | KLRC4 | killer cell lectin like receptor C4 | 2 | 2 | ||||||||
MIRT448778 | GNA13 | G protein subunit alpha 13 | 2 | 2 | ||||||||
MIRT449290 | GMNC | geminin coiled-coil domain containing | 2 | 2 | ||||||||
MIRT449673 | SOX3 | SRY-box 3 | 2 | 2 | ||||||||
MIRT450020 | EPM2AIP1 | EPM2A interacting protein 1 | 2 | 2 | ||||||||
MIRT450089 | OR2A4 | olfactory receptor family 2 subfamily A member 4 | 2 | 2 | ||||||||
MIRT450209 | PAIP1 | poly(A) binding protein interacting protein 1 | 2 | 2 | ||||||||
MIRT450271 | F2RL2 | coagulation factor II thrombin receptor like 2 | 2 | 2 | ||||||||
MIRT450402 | TMEM47 | transmembrane protein 47 | 2 | 2 | ||||||||
MIRT450419 | BCL2L14 | BCL2 like 14 | 2 | 2 | ||||||||
MIRT450598 | EXOC2 | exocyst complex component 2 | 2 | 2 | ||||||||
MIRT450821 | KCNB1 | potassium voltage-gated channel subfamily B member 1 | 2 | 2 | ||||||||
MIRT453007 | CCDC115 | coiled-coil domain containing 115 | 2 | 17 | ||||||||
MIRT453857 | ZNF12 | zinc finger protein 12 | 2 | 2 | ||||||||
MIRT454706 | HMGN1 | high mobility group nucleosome binding domain 1 | 2 | 4 | ||||||||
MIRT458699 | LEPREL1 | prolyl 3-hydroxylase 2 | 1 | 1 | ||||||||
MIRT465144 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT468216 | SGK1 | serum/glucocorticoid regulated kinase 1 | 2 | 2 | ||||||||
MIRT469657 | RAC1 | Rac family small GTPase 1 | 2 | 2 | ||||||||
MIRT470155 | PSME3 | proteasome activator subunit 3 | 2 | 2 | ||||||||
MIRT470287 | PRDX5 | peroxiredoxin 5 | 2 | 2 | ||||||||
MIRT470296 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT472433 | NCBP2 | nuclear cap binding protein subunit 2 | 2 | 2 | ||||||||
MIRT472459 | NASP | nuclear autoantigenic sperm protein | 2 | 2 | ||||||||
MIRT475265 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | 2 | 2 | ||||||||
MIRT476735 | FOXN2 | forkhead box N2 | 2 | 2 | ||||||||
MIRT476757 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT477549 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 2 | ||||||||
MIRT478797 | CRTAP | cartilage associated protein | 2 | 4 | ||||||||
MIRT479661 | CD164 | CD164 molecule | 2 | 4 | ||||||||
MIRT479893 | CCDC117 | coiled-coil domain containing 117 | 2 | 4 | ||||||||
MIRT480325 | C5orf51 | chromosome 5 open reading frame 51 | 2 | 2 | ||||||||
MIRT481229 | ATXN7L3 | ataxin 7 like 3 | 2 | 2 | ||||||||
MIRT484088 | SUGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 2 | 2 | ||||||||
MIRT487507 | GRK5 | G protein-coupled receptor kinase 5 | 2 | 2 | ||||||||
MIRT488356 | PAX2 | paired box 2 | 2 | 2 | ||||||||
MIRT496746 | PDIK1L | PDLIM1 interacting kinase 1 like | 2 | 2 | ||||||||
MIRT496832 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT500913 | STARD13 | StAR related lipid transfer domain containing 13 | 2 | 4 | ||||||||
MIRT502256 | HNRNPF | heterogeneous nuclear ribonucleoprotein F | 2 | 4 | ||||||||
MIRT504078 | C9orf40 | chromosome 9 open reading frame 40 | 2 | 6 | ||||||||
MIRT504890 | MRPL51 | mitochondrial ribosomal protein L51 | 2 | 4 | ||||||||
MIRT509834 | TACR3 | tachykinin receptor 3 | 2 | 4 | ||||||||
MIRT511989 | E2F8 | E2F transcription factor 8 | 2 | 4 | ||||||||
MIRT524543 | CDC5L | cell division cycle 5 like | 2 | 4 | ||||||||
MIRT526673 | ZNF791 | zinc finger protein 791 | 2 | 2 | ||||||||
MIRT527410 | SMU1 | DNA replication regulator and spliceosomal factor | 2 | 2 | ||||||||
MIRT528393 | PGK1 | phosphoglycerate kinase 1 | 2 | 2 | ||||||||
MIRT529318 | PDE5A | phosphodiesterase 5A | 2 | 2 | ||||||||
MIRT529844 | SMTN | smoothelin | 2 | 2 | ||||||||
MIRT531461 | TNFRSF10B | TNF receptor superfamily member 10b | 2 | 4 | ||||||||
MIRT535096 | PODXL | podocalyxin like | 2 | 2 | ||||||||
MIRT535294 | PHF6 | PHD finger protein 6 | 2 | 2 | ||||||||
MIRT537542 | ETS1 | ETS proto-oncogene 1, transcription factor | 2 | 2 | ||||||||
MIRT540200 | ARHGAP18 | Rho GTPase activating protein 18 | 2 | 2 | ||||||||
MIRT543416 | C5orf42 | chromosome 5 open reading frame 42 | 2 | 2 | ||||||||
MIRT543873 | SLC16A9 | solute carrier family 16 member 9 | 2 | 2 | ||||||||
MIRT544393 | SMC5 | structural maintenance of chromosomes 5 | 2 | 2 | ||||||||
MIRT544919 | MBLAC2 | metallo-beta-lactamase domain containing 2 | 2 | 2 | ||||||||
MIRT546579 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT548834 | CHD1 | chromodomain helicase DNA binding protein 1 | 2 | 4 | ||||||||
MIRT550787 | WARS2 | tryptophanyl tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT553434 | TPM3 | tropomyosin 3 | 2 | 2 | ||||||||
MIRT557467 | GRB10 | growth factor receptor bound protein 10 | 2 | 4 | ||||||||
MIRT558065 | ESCO2 | establishment of sister chromatid cohesion N-acetyltransferase 2 | 2 | 2 | ||||||||
MIRT558258 | DYNLL2 | dynein light chain LC8-type 2 | 2 | 2 | ||||||||
MIRT559205 | BLOC1S6 | biogenesis of lysosomal organelles complex 1 subunit 6 | 2 | 2 | ||||||||
MIRT561072 | SRRM4 | serine/arginine repetitive matrix 4 | 2 | 2 | ||||||||
MIRT561805 | PAPD5 | poly(A) RNA polymerase D5, non-canonical | 2 | 2 | ||||||||
MIRT563875 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | 2 | 4 | ||||||||
MIRT565835 | SCML2 | Scm polycomb group protein like 2 | 2 | 2 | ||||||||
MIRT568049 | CHSY1 | chondroitin sulfate synthase 1 | 2 | 2 | ||||||||
MIRT572820 | MYO1C | myosin IC | 2 | 2 | ||||||||
MIRT575423 | Epg5 | ectopic P-granules autophagy protein 5 homolog (C. elegans) | 2 | 4 | ||||||||
MIRT576435 | Ccdc115 | coiled-coil domain containing 115 | 2 | 10 | ||||||||
MIRT576533 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT611715 | EPG5 | ectopic P-granules autophagy protein 5 homolog | 2 | 5 | ||||||||
MIRT612574 | RBBP5 | RB binding protein 5, histone lysine methyltransferase complex subunit | 2 | 2 | ||||||||
MIRT613945 | IFIT3 | interferon induced protein with tetratricopeptide repeats 3 | 2 | 2 | ||||||||
MIRT614279 | WSCD2 | WSC domain containing 2 | 2 | 2 | ||||||||
MIRT615194 | CLUAP1 | clusterin associated protein 1 | 2 | 2 | ||||||||
MIRT627995 | MTA3 | metastasis associated 1 family member 3 | 2 | 2 | ||||||||
MIRT637069 | DENND2C | DENN domain containing 2C | 2 | 2 | ||||||||
MIRT639912 | SLIT1 | slit guidance ligand 1 | 2 | 2 | ||||||||
MIRT642026 | MYADM | myeloid associated differentiation marker | 2 | 2 | ||||||||
MIRT642844 | SLC5A8 | solute carrier family 5 member 8 | 2 | 2 | ||||||||
MIRT643706 | ZNF736 | zinc finger protein 736 | 2 | 2 | ||||||||
MIRT643835 | RBMY1J | RNA binding motif protein, Y-linked, family 1, member J | 2 | 2 | ||||||||
MIRT644775 | RBMY1B | RNA binding motif protein, Y-linked, family 1, member B | 2 | 2 | ||||||||
MIRT644778 | RBMY1A1 | RNA binding motif protein, Y-linked, family 1, member A1 | 2 | 2 | ||||||||
MIRT644781 | RBMY1D | RNA binding motif protein, Y-linked, family 1, member D | 2 | 2 | ||||||||
MIRT644784 | RBMY1E | RNA binding motif protein, Y-linked, family 1, member E | 2 | 2 | ||||||||
MIRT647495 | ZNF639 | zinc finger protein 639 | 2 | 2 | ||||||||
MIRT648248 | RBMY1F | RNA binding motif protein, Y-linked, family 1, member F | 2 | 2 | ||||||||
MIRT648633 | LEMD2 | LEM domain containing 2 | 2 | 2 | ||||||||
MIRT654626 | PTGFR | prostaglandin F receptor | 2 | 2 | ||||||||
MIRT656345 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT657354 | HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 2 | 2 | ||||||||
MIRT659635 | CDKN2AIP | CDKN2A interacting protein | 2 | 2 | ||||||||
MIRT659651 | CDH4 | cadherin 4 | 2 | 2 | ||||||||
MIRT660959 | ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | 2 | 2 | ||||||||
MIRT664139 | ATP6V1G3 | ATPase H+ transporting V1 subunit G3 | 2 | 2 | ||||||||
MIRT666038 | STRBP | spermatid perinuclear RNA binding protein | 2 | 2 | ||||||||
MIRT666200 | SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 | 2 | 2 | ||||||||
MIRT681712 | GDF6 | growth differentiation factor 6 | 2 | 2 | ||||||||
MIRT683276 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT690312 | MRPS30 | mitochondrial ribosomal protein S30 | 2 | 2 | ||||||||
MIRT691642 | SLC43A3 | solute carrier family 43 member 3 | 2 | 2 | ||||||||
MIRT692270 | GPR157 | G protein-coupled receptor 157 | 2 | 2 | ||||||||
MIRT692840 | C1orf50 | chromosome 1 open reading frame 50 | 2 | 2 | ||||||||
MIRT697820 | UBQLN1 | ubiquilin 1 | 2 | 2 | ||||||||
MIRT698248 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT702755 | IGF1R | insulin like growth factor 1 receptor | 2 | 2 | ||||||||
MIRT702918 | CRAMP1L | cramped chromatin regulator homolog 1 | 2 | 2 | ||||||||
MIRT703411 | FYTTD1 | forty-two-three domain containing 1 | 2 | 2 | ||||||||
MIRT704857 | CD46 | CD46 molecule | 2 | 2 | ||||||||
MIRT711066 | BTD | biotinidase | 2 | 2 | ||||||||
MIRT717794 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT719676 | SPDYE1 | speedy/RINGO cell cycle regulator family member E1 | 2 | 2 | ||||||||
MIRT720300 | DDHD1 | DDHD domain containing 1 | 2 | 2 | ||||||||
MIRT723496 | WDR33 | WD repeat domain 33 | 2 | 2 | ||||||||
MIRT723934 | SVOP | SV2 related protein | 2 | 2 | ||||||||
MIRT735586 | FUT8 | fucosyltransferase 8 | 2 | 0 | ||||||||
MIRT735935 | EYA3 | EYA transcriptional coactivator and phosphatase 3 | 3 | 0 | ||||||||
MIRT756075 | HDAC1 | histone deacetylase 1 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|